Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Goldstein

Showing results (1131-1140 of 1,434) with videos related to

Pageof 144
Sort By:
Molecular Psychiatry|February 24, 2006
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetineN Müller, M J Schwarz, S Dehning, et al.
Nature Genetics|December 8, 2009
Geographical genomics of human leukocyte gene expression variation in southern MoroccoYoussef Idaghdour, Wendy Czika, Kevin V Shianna, et al.
The Journal of Investigative Dermatology|November 30, 2012
MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD)Steven N Reuland, Shilo M Smith, Lynne T Bemis, et al.
International Journal of Epidemiology|October 3, 2018
Early life disadvantage and adult adiposity: tests of sensitive periods during childhood and behavioural mediation in adulthoodStephen E Gilman, Yen-Tsung Huang, Marcia P Jimenez, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 23, 2016
Reduction of carbamylated albumin by extended hemodialysisJeffrey Perl, Sahir Kalim, Ron Wald, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2021
High-impact rare genetic variants in severe schizophreniaAnthony W Zoghbi, Ryan S Dhindsa, Terry E Goldberg, et al.
Stroke|August 20, 2011
Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapiesGregory W Albers, Larry B Goldstein, David C Hess, et al.
Science (New York, N.Y.)|February 26, 2005
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's diseaseGorazd B Stokin, Concepción Lillo, Tomás L Falzone, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 18, 2025
Association Between Marital/Partner Status and Patient-reported Outcomes in Stroke Patients: A Systematic ReviewCenjing Zhu, Phoebe M Tran, Erica C Leifheit, et al.
Medical Care|March 22, 2005
Insurance coverage, usual source of care, and receipt of clinically indicated care for comorbid conditions among adults living with human immunodeficiency virusRisë B Goldstein, Mary Jane Rotheram-Borus, Mallory O Johnson, et al.
Pageof 144

Showing results (1131-1140 of 1,434) with videos related to

Sort By:
Pageof 144
Molecular Psychiatry|February 24, 2006
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetineN Müller, M J Schwarz, S Dehning, et al.
Nature Genetics|December 8, 2009
Geographical genomics of human leukocyte gene expression variation in southern MoroccoYoussef Idaghdour, Wendy Czika, Kevin V Shianna, et al.
The Journal of Investigative Dermatology|November 30, 2012
MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD)Steven N Reuland, Shilo M Smith, Lynne T Bemis, et al.
International Journal of Epidemiology|October 3, 2018
Early life disadvantage and adult adiposity: tests of sensitive periods during childhood and behavioural mediation in adulthoodStephen E Gilman, Yen-Tsung Huang, Marcia P Jimenez, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 23, 2016
Reduction of carbamylated albumin by extended hemodialysisJeffrey Perl, Sahir Kalim, Ron Wald, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2021
High-impact rare genetic variants in severe schizophreniaAnthony W Zoghbi, Ryan S Dhindsa, Terry E Goldberg, et al.
Stroke|August 20, 2011
Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapiesGregory W Albers, Larry B Goldstein, David C Hess, et al.
Science (New York, N.Y.)|February 26, 2005
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's diseaseGorazd B Stokin, Concepción Lillo, Tomás L Falzone, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 18, 2025
Association Between Marital/Partner Status and Patient-reported Outcomes in Stroke Patients: A Systematic ReviewCenjing Zhu, Phoebe M Tran, Erica C Leifheit, et al.
Medical Care|March 22, 2005
Insurance coverage, usual source of care, and receipt of clinically indicated care for comorbid conditions among adults living with human immunodeficiency virusRisë B Goldstein, Mary Jane Rotheram-Borus, Mallory O Johnson, et al.
Pageof 144